Stegostoma fasciatum isolate 6-17 chromosome 28, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039254.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
ectonucleoside triphosphate diphosphohydrolase 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
NOTCH regulated ankyrin repeat protein a
notch-regulated ankyrin repeat-containing protein A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
MAM domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAM domain containing 4, transcript variant X3
MAM domain containing 4, transcript variant X1
apical endosomal glycoprotein isoform X3
apical endosomal glycoprotein isoform X1
apical endosomal glycoprotein isoform X2
TruB pseudouridine (psi) synthase family member 2, transcript variant X2
TruB pseudouridine (psi) synthase family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase TRUB2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ubiquinone biosynthesis protein COQ4 homolog, mitochondrial
peptidylprolyl isomerase (cyclophilin)-like 3, transcript variant X2
peptidylprolyl isomerase (cyclophilin)-like 3, transcript variant X1
peptidylprolyl isomerase (cyclophilin)-like 3, transcript variant X3
peptidyl-prolyl cis-trans isomerase-like 3 isoform X2
peptidyl-prolyl cis-trans isomerase-like 3 isoform X1
peptidyl-prolyl cis-trans isomerase-like 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
suppressor APC domain-containing protein 2
UDP-N-acetylhexosamine pyrophosphorylase-like protein 1
endothelial differentiation-related factor 1
endothelial differentiation-related factor 1 homolog
protein AMBP-like, transcript variant X2
protein AMBP-like, transcript variant X1
complement component 8, gamma polypeptide, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
complement component 8, gamma polypeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
complement component C8 gamma chain isoform X1
complement component C8 gamma chain isoform X2
Tnf receptor-associated factor 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Tnf receptor-associated factor 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Tnf receptor-associated factor 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Tnf receptor-associated factor 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Tnf receptor-associated factor 2b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain-containing protein 183-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent phosphate transport protein 2C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 599 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubulin beta chain-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 626 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
tubulin beta chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
aminolevulinate dehydratase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
aminolevulinate dehydratase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
aminolevulinate dehydratase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
aminolevulinate dehydratase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
NADPH dependent diflavin oxidoreductase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
NADPH dependent diflavin oxidoreductase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NADPH-dependent diflavin oxidoreductase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, NMDA 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1, transcript variant X4
glutamate receptor ionotropic, NMDA 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X4
glutamate receptor ionotropic, NMDA 1 isoform X6
glutamate receptor ionotropic, NMDA 1 isoform X1
glutamate receptor ionotropic, NMDA 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, NMDA 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X7
glutamate receptor ionotropic, NMDA 1 isoform X2
glutamate receptor ionotropic, NMDA 1, transcript variant X3
glutamate receptor ionotropic, NMDA 1 isoform X3
glutamate receptor ionotropic, NMDA 1, transcript variant X9
glutamate receptor ionotropic, NMDA 1 isoform X9
glutamate receptor ionotropic, NMDA 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X5
glutamate receptor ionotropic, NMDA 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat protein 28-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
discoidin domain receptor family, member 2, like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
GLI pathogenesis-related 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein glipr2 isoform X1
GLI pathogenesis-related 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
GLI pathogenesis-related 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein glipr2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 462 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
haloacid dehalogenase-like hydrolase domain containing 3
haloacid dehalogenase-like hydrolase domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
B box and SPRY domain-containing protein
ganglioside GM2 activator-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ganglioside GM2 activator-like, transcript variant X1
ganglioside GM2 activator-like isoform X1
ganglioside GM2 activator-like isoform X2
ganglioside GM2 activator-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ganglioside GM2 activator-like isoform X3
WD repeat domain 31, transcript variant X3
WD repeat domain 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
WD repeat domain 31, transcript variant X2
WD repeat-containing protein 31 isoform X1
WD repeat-containing protein 31 isoform X2
WD repeat-containing protein 31 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PRP4 pre-mRNA processing factor 4 homolog (yeast), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
PRP4 pre-mRNA processing factor 4 homolog (yeast), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X1
U4/U6 small nuclear ribonucleoprotein Prp4 isoform X2
anaphase-promoting complex subunit CDC26
solute carrier family 31 member 1, transcript variant X3
solute carrier family 31 member 1, transcript variant X2
solute carrier family 31 member 1, transcript variant X1
high affinity copper uptake protein 1 isoform X1
high affinity copper uptake protein 1 isoform X2
FKBP prolyl isomerase family member 15a, transcript variant X1
FKBP prolyl isomerase family member 15a, transcript variant X3
FKBP prolyl isomerase family member 15a, transcript variant X2
FKBP prolyl isomerase family member 15a, transcript variant X4
leucine rich repeat and sterile alpha motif containing 1, transcript variant X3
leucine rich repeat and sterile alpha motif containing 1, transcript variant X2
leucine rich repeat and sterile alpha motif containing 1, transcript variant X1
leucine rich repeat and sterile alpha motif containing 1, transcript variant X4
E3 ubiquitin-protein ligase LRSAM1 isoform X2
E3 ubiquitin-protein ligase LRSAM1 isoform X1
E3 ubiquitin-protein ligase LRSAM1 isoform X3
polymerase (DNA directed), epsilon 3 (p17 subunit), transcript variant X2
polymerase (DNA directed), epsilon 3 (p17 subunit), transcript variant X5
polymerase (DNA directed), epsilon 3 (p17 subunit), transcript variant X4
polymerase (DNA directed), epsilon 3 (p17 subunit), transcript variant X3
polymerase (DNA directed), epsilon 3 (p17 subunit), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125465551, transcript variant X2
uncharacterized LOC125465551, transcript variant X1
uncharacterized protein LOC125465551 isoform X2
uncharacterized protein LOC125465551 isoform X1
ATP-binding cassette, sub-family A (ABC1), member 2
ATP-binding cassette sub-family A member 2
chloride intracellular channel protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 5, transcription factor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 5, transcription factor 1
neural proliferation differentiation and control protein 1-like
NMDA receptor synaptonuclear signaling and neuronal migration factor b
NMDA receptor synaptonuclear signaling and neuronal migration factor
patatin-like phospholipase domain containing 7b, transcript variant X1
patatin-like phospholipase domain containing 7b, transcript variant X2
patatin-like phospholipase domain-containing protein 7 isoform X1
patatin-like phospholipase domain-containing protein 7 isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
mitochondrial ribosomal protein L41, transcript variant X1
mitochondrial ribosomal protein L41, transcript variant X3
mitochondrial ribosomal protein L41, transcript variant X4
mitochondrial ribosomal protein L41, transcript variant X2
39S ribosomal protein L41, mitochondrial
diphthamide biosynthesis 7, transcript variant X2
diphthamide biosynthesis 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger MYND domain-containing protein 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125465222, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125465222, transcript variant X2
uncharacterized LOC125465222, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bone morphogenetic protein/retinoic acid inducible neural-specific 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bone morphogenetic protein/retinoic acid inducible neural-specific 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BMP/retinoic acid-inducible neural-specific protein 1
astrotactin-2-like, transcript variant X1
astrotactin-2-like, transcript variant X2
astrotactin-2-like, transcript variant X3
pappalysin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pappalysin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pappalysin-1-like, transcript variant X1
uncharacterized LOC125465427, transcript variant X1
uncharacterized LOC125465427, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125465427, transcript variant X3
uncharacterized LOC125465427, transcript variant X4
uncharacterized LOC125465427, transcript variant X5
uncharacterized LOC125465427, transcript variant X7
uncharacterized LOC125465427, transcript variant X6
dual specificity testis-specific protein kinase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dual specificity testis-specific protein kinase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dual specificity testis-specific protein kinase 2-like isoform X1
dual specificity testis-specific protein kinase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
mannosidase, alpha, class 1B, member 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mannosidase, alpha, class 1B, member 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mannosidase, alpha, class 1B, member 1b isoform X2
mannosidase, alpha, class 1B, member 1b isoform X1
collagen alpha-1(I) chain-like, transcript variant X2
collagen alpha-1(I) chain-like, transcript variant X1
collagen alpha-1(I) chain-like, transcript variant X3
collagen alpha-1(I) chain-like isoform X2
collagen alpha-1(I) chain-like isoform X1
collagen alpha-1(I) chain-like isoform X3
collagen alpha-1(I) chain-like, transcript variant X4
calcium channel, voltage-dependent, N type, alpha 1B subunit, a
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
euchromatic histone-lysine N-methyltransferase 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
histone-lysine N-methyltransferase EHMT1 isoform X3
histone-lysine N-methyltransferase EHMT1 isoform X6
histone-lysine N-methyltransferase EHMT1 isoform X5
histone-lysine N-methyltransferase EHMT1 isoform X2
histone-lysine N-methyltransferase EHMT1 isoform X1
histone-lysine N-methyltransferase EHMT1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glutamine synthetase-like, transcript variant X3
glutamine synthetase-like, transcript variant X2
glutamine synthetase-like, transcript variant X1
lysophosphatidic acid receptor 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125465479, transcript variant X2
uncharacterized LOC125465479, transcript variant X4
uncharacterized LOC125465479, transcript variant X3
uncharacterized LOC125465479, transcript variant X5
uncharacterized LOC125465479, transcript variant X1
negative elongation factor complex member B
ER degradation-enhancing alpha-mannosidase-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 3
syntaxin-binding protein 1, transcript variant X3
syntaxin-binding protein 1, transcript variant X1
syntaxin-binding protein 1, transcript variant X2
AT-hook transcription factor, transcript variant X2
AT-hook transcription factor, transcript variant X1
AT-hook transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: V-type proton ATPase subunit G 1-like
multiple epidermal growth factor-like domains protein 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 15-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tumor necrosis factor ligand superfamily member 15-like, transcript variant X3
tumor necrosis factor ligand superfamily member 15-like, transcript variant X6
tumor necrosis factor ligand superfamily member 15-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 15-like isoform X4
tumor necrosis factor ligand superfamily member 15-like isoform X1
tumor necrosis factor ligand superfamily member 15-like, transcript variant X4
tumor necrosis factor ligand superfamily member 15-like, transcript variant X5
tumor necrosis factor ligand superfamily member 15-like isoform X2
tumor necrosis factor ligand superfamily member 15-like isoform X3
tumor necrosis factor ligand superfamily member 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
regulator of G protein signaling 3a, transcript variant X1
regulator of G-protein signaling 3a isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins
regulator of G protein signaling 3a, transcript variant X3
regulator of G-protein signaling 3a isoform X3
regulator of G protein signaling 3a, transcript variant X2
regulator of G-protein signaling 3a isoform X2
uncharacterized LOC125465497, transcript variant X2
uncharacterized LOC125465497, transcript variant X1
uncharacterized LOC125465497, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
zinc finger protein 618, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger protein 618, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 618, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein 618, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
zinc finger protein 618, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125465512, transcript variant X2
uncharacterized LOC125465512, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
probable G-protein coupled receptor 34, transcript variant X2
probable G-protein coupled receptor 34, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X7
CDK5 regulatory subunit associated protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 2 isoform X7
CDK5 regulatory subunit-associated protein 2 isoform X8
CDK5 regulatory subunit associated protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X1
CDK5 regulatory subunit associated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X6
CDK5 regulatory subunit associated protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CDK5 regulatory subunit-associated protein 2 isoform X3
CDK5 regulatory subunit-associated protein 2 isoform X4
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit-associated protein 2 isoform X2
CDK5 regulatory subunit-associated protein 2 isoform X6
CDK5 regulatory subunit-associated protein 2 isoform X5
uncharacterized LOC125465490, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125465490, transcript variant X2
uncharacterized protein LOC125465490 isoform X1
uncharacterized protein LOC125465490 isoform X2
ribosomal protein L28, transcript variant X2
ribosomal protein L28, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ribosome-recycling factor, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A8
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8
uncharacterized protein LOC559906 homolog, transcript variant X2
uncharacterized protein LOC559906 homolog, transcript variant X1
keratin, type I cytoskeletal 18 isoform X1
keratin, type I cytoskeletal 18 isoform X2
uncharacterized LOC125465336, transcript variant X2
uncharacterized LOC125465336, transcript variant X1
zinc finger and BTB domain containing 26, transcript variant X2
zinc finger and BTB domain containing 26, transcript variant X1
zinc finger and BTB domain-containing protein 26 isoform X1
zinc finger and BTB domain-containing protein 26 isoform X2
ring finger and CCCH-type domains 2, transcript variant X3
ring finger and CCCH-type domains 2, transcript variant X4
ring finger and CCCH-type domains 2, transcript variant X1
ring finger and CCCH-type domains 2, transcript variant X5
ring finger and CCCH-type domains 2, transcript variant X7
ring finger and CCCH-type domains 2, transcript variant X6
ring finger and CCCH-type domains 2, transcript variant X8
ring finger and CCCH-type domains 2, transcript variant X9
ring finger and CCCH-type domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
spermatid perinuclear RNA binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
spermatid perinuclear RNA-binding protein isoform X3
spermatid perinuclear RNA-binding protein isoform X1
spermatid perinuclear RNA binding protein, transcript variant X3
spermatid perinuclear RNA-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
DENN domain-containing protein 1A-like, transcript variant X3
DENN domain-containing protein 1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DENN domain-containing protein 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DENN domain-containing protein 1A-like isoform X3
DENN domain-containing protein 1A-like isoform X2
DENN domain-containing protein 1A-like isoform X1
uncharacterized LOC125465464, transcript variant X2
uncharacterized LOC125465464, transcript variant X4
uncharacterized LOC125465464, transcript variant X3
uncharacterized LOC125465464, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: LIM/homeobox protein Lhx2-like
serine/threonine-protein kinase Nek6-like, transcript variant X5
serine/threonine-protein kinase Nek6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
serine/threonine-protein kinase Nek6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/threonine-protein kinase Nek6-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase Nek6-like, transcript variant X1
serine/threonine-protein kinase Nek6-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase Nek6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
serine/threonine-protein kinase Nek6-like, transcript variant X7
serine/threonine-protein kinase Nek6-like
adhesion G protein-coupled receptor D2, transcript variant X4
adhesion G protein-coupled receptor D2, transcript variant X2
adhesion G protein-coupled receptor D2, transcript variant X3
adhesion G protein-coupled receptor D2, transcript variant X1
adhesion G protein-coupled receptor D2, transcript variant X6
adhesion G protein-coupled receptor D2, transcript variant X8
adhesion G protein-coupled receptor D2, transcript variant X7
adhesion G protein-coupled receptor D2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor D2, transcript variant X5
adhesion G-protein coupled receptor D2 isoform X2
adhesion G-protein coupled receptor D2 isoform X1
adhesion G-protein coupled receptor D2 isoform X4
adhesion G-protein coupled receptor D2 isoform X3
adhesion G-protein coupled receptor D2 isoform X5
nuclear receptor subfamily 5 group A member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear receptor subfamily 6 group A member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear receptor subfamily 6 group A member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear receptor subfamily 6 group A member 1 isoform X1
nuclear receptor subfamily 6 group A member 1 isoform X2
uncharacterized LOC125465477, transcript variant X2
uncharacterized LOC125465477, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
actin related protein 2/3 complex, subunit 5-like, b
suppressor of cancer cell invasion, transcript variant X5
suppressor of cancer cell invasion, transcript variant X1
suppressor of cancer cell invasion, transcript variant X3
suppressor of cancer cell invasion, transcript variant X2
suppressor of cancer cell invasion, transcript variant X4
suppressor of cancer cell invasion, transcript variant X6
protein phosphatase 6, catalytic subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein phosphatase 6, catalytic subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
serine/threonine-protein phosphatase 6 catalytic subunit isoform X2
serine/threonine-protein phosphatase 6 catalytic subunit isoform X1
Rab9 effector protein with kelch motifs, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Rab9 effector protein with kelch motifs, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
GTPase activating protein and VPS9 domains 1, transcript variant X6
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X1
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X2
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X4
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X3
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X5
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X6
MAPK associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MAPK associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X7
MAPK associated protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
target of rapamycin complex 2 subunit MAPKAP1 isoform X2
target of rapamycin complex 2 subunit MAPKAP1 isoform X1
target of rapamycin complex 2 subunit MAPKAP1 isoform X3
target of rapamycin complex 2 subunit MAPKAP1 isoform X5
MAPK associated protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
target of rapamycin complex 2 subunit MAPKAP1 isoform X4
pre-B-cell leukemia homeobox 3b, transcript variant X1
pre-B-cell leukemia homeobox 3b, transcript variant X4
pre-B-cell leukemia homeobox 3b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3b isoform X1
pre-B-cell leukemia transcription factor 3b isoform X2
pre-B-cell leukemia transcription factor 3b isoform X4
pre-B-cell leukemia homeobox 3b, transcript variant X3
pre-B-cell leukemia transcription factor 3b isoform X3
pre-B-cell leukemia homeobox 3b, transcript variant X5
pre-B-cell leukemia transcription factor 3b isoform X5
multivesicular body subunit 12Ba, transcript variant X3
multivesicular body subunit 12Ba, transcript variant X1
multivesicular body subunit 12Ba, transcript variant X2
multivesicular body subunit 12Ba isoform X1
multivesicular body subunit 12Ba isoform X2
multivesicular body subunit 12Ba, transcript variant X4
multivesicular body subunit 12Ba isoform X3
LIM/homeobox protein LMX-1.2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM/homeobox protein LMX-1.2, transcript variant X5
LIM/homeobox protein LMX-1.2, transcript variant X1
LIM/homeobox protein LMX-1.2, transcript variant X3
LIM/homeobox protein LMX-1.2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain containing 43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 43
family with sequence similarity 183 member A, transcript variant X2
family with sequence similarity 183 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain containing 34, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain containing 34, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger and BTB domain containing 34, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 34 isoform X1
zinc finger and BTB domain containing 34, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 34 isoform X2
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X5
ras-specific guanine nucleotide-releasing factor RalGPS1-like, transcript variant X6
ras-specific guanine nucleotide-releasing factor RalGPS1-like isoform X1
ras-specific guanine nucleotide-releasing factor RalGPS1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
F-box and WD repeat domain containing 2, transcript variant X2
F-box and WD repeat domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
F-box/WD repeat-containing protein 2 isoform X2
F-box/WD repeat-containing protein 2 isoform X1
solute carrier family 2 member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 2 member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 8 isoform X1
solute carrier family 2, facilitated glucose transporter member 8 isoform X2
GTPase activating Rap/RanGAP domain like 3, transcript variant X5
GTPase activating Rap/RanGAP domain like 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase activating Rap/RanGAP domain like 3, transcript variant X7
GTPase activating Rap/RanGAP domain like 3, transcript variant X1
GTPase activating Rap/RanGAP domain like 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
GTPase activating Rap/RanGAP domain like 3, transcript variant X3
GTPase activating Rap/RanGAP domain like 3, transcript variant X8
GTPase activating Rap/RanGAP domain like 3, transcript variant X2
GTPase activating Rap/RanGAP domain like 3, transcript variant X6
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X4
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X9
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X3
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X8
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X2
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X6
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X5
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X7
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X1
GTPase activating Rap/RanGAP domain like 3, transcript variant X10
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X10
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X3
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
tubulin tyrosine ligase-like family, member 11
disabled homolog 2-interacting protein-like, transcript variant X3
disabled homolog 2-interacting protein-like, transcript variant X1
disabled homolog 2-interacting protein-like, transcript variant X2
disabled homolog 2-interacting protein-like, transcript variant X6
disabled homolog 2-interacting protein-like, transcript variant X5
disabled homolog 2-interacting protein-like, transcript variant X7
disabled homolog 2-interacting protein-like, transcript variant X4
disabled homolog 2-interacting protein-like, transcript variant X8
disabled homolog 2-interacting protein-like, transcript variant X9
disabled homolog 2-interacting protein-like, transcript variant X12
disabled homolog 2-interacting protein-like, transcript variant X11
disabled homolog 2-interacting protein-like, transcript variant X10
disabled homolog 2-interacting protein-like isoform X3
disabled homolog 2-interacting protein-like isoform X1
disabled homolog 2-interacting protein-like isoform X2
disabled homolog 2-interacting protein-like isoform X5
disabled homolog 2-interacting protein-like isoform X4
disabled homolog 2-interacting protein-like isoform X6
disabled homolog 2-interacting protein-like isoform X7
disabled homolog 2-interacting protein-like isoform X8
protein CutA homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein CutA homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
TNF receptor-associated factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TNF receptor-associated factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ras-related protein Rab-14, transcript variant X7
ras-related protein Rab-14, transcript variant X3
ras-related protein Rab-14, transcript variant X6
ras-related protein Rab-14, transcript variant X1
ras-related protein Rab-14, transcript variant X4
ras-related protein Rab-14, transcript variant X8
ras-related protein Rab-14, transcript variant X2
ras-related protein Rab-14, transcript variant X5
ras-related protein Rab-14, transcript variant X9
erythrocyte band 7 integral membrane protein
tetratricopeptide repeat protein 16-like, transcript variant X2
tetratricopeptide repeat protein 16-like, transcript variant X1
tetratricopeptide repeat protein 16-like isoform X2
tetratricopeptide repeat protein 16-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
sperm acrosome associated 9, transcript variant X3
sperm acrosome-associated protein 9 isoform X2
sperm acrosome associated 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
sperm acrosome associated 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sperm acrosome-associated protein 9 isoform X1
adenylate kinase 8, transcript variant X2
adenylate kinase 8, transcript variant X3
adenylate kinase 8, transcript variant X1
adenylate kinase 8, transcript variant X4
adenylate kinase 8, transcript variant X5
adenylate kinase 8, transcript variant X6
general transcription factor IIIC, polypeptide 4
general transcription factor 3C polypeptide 4
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125465576, transcript variant X1
uncharacterized LOC125465576, transcript variant X2
cilia and flagella associated protein 77
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cilia- and flagella-associated protein 77
transcription termination factor 1-like, transcript variant X4
transcription termination factor 1-like, transcript variant X3
transcription termination factor 1-like, transcript variant X1
transcription termination factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator complex subunit 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mediator complex subunit 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mediator complex subunit 27, transcript variant X3
mediator of RNA polymerase II transcription subunit 27 isoform X1
mediator of RNA polymerase II transcription subunit 27 isoform X2
mediator of RNA polymerase II transcription subunit 27 isoform X3
rap guanine nucleotide exchange factor 1-like, transcript variant X1
rap guanine nucleotide exchange factor 1-like, transcript variant X2
rap guanine nucleotide exchange factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rap guanine nucleotide exchange factor 1-like, transcript variant X4
rap guanine nucleotide exchange factor 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rap guanine nucleotide exchange factor 1-like, transcript variant X6
rap guanine nucleotide exchange factor 1-like isoform X1
rap guanine nucleotide exchange factor 1-like isoform X2
rap guanine nucleotide exchange factor 1-like isoform X3
rap guanine nucleotide exchange factor 1-like isoform X4
rap guanine nucleotide exchange factor 1-like isoform X5
rap guanine nucleotide exchange factor 1-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X5
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X2
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X2
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X1
volume-regulated anion channel subunit LRRC8D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat containing 8 VRAC subunit Aa, transcript variant X2
leucine rich repeat containing 8 VRAC subunit Aa, transcript variant X1
leucine rich repeat containing 8 VRAC subunit Aa, transcript variant X3
leucine rich repeat containing 8 VRAC subunit Aa, transcript variant X4
leucine rich repeat containing 8 VRAC subunit Aa
kynurenine--oxoglutarate transaminase 1-like, transcript variant X4
kynurenine--oxoglutarate transaminase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
kynurenine--oxoglutarate transaminase 1-like isoform X1
kynurenine--oxoglutarate transaminase 3-like isoform X2
kynurenine--oxoglutarate transaminase 3-like isoform X3
uncharacterized LOC125465521, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125465521, transcript variant X2
transforming growth factor beta receptor type 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transforming growth factor beta receptor type 3-like, transcript variant X2
transforming growth factor beta receptor type 3-like
folylpolyglutamate synthase, transcript variant X2
folylpolyglutamate synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
folylpolyglutamate synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
folylpolyglutamate synthase, mitochondrial isoform X2
folylpolyglutamate synthase, mitochondrial isoform X1
folylpolyglutamate synthase, mitochondrial isoform X3
cyclin-dependent kinase 9 (CDC2-related kinase)
SH2 domain-containing protein 3C-like, transcript variant X1
SH2 domain-containing protein 3C-like, transcript variant X2
SH2 domain-containing protein 3C-like, transcript variant X4
SH2 domain-containing protein 3C-like isoform X1
SH2 domain-containing protein 3C-like isoform X2
SH2 domain-containing protein 3C-like, transcript variant X3
SH2 domain-containing protein 3C-like isoform X3
SH2 domain-containing protein 3C-like, transcript variant X6
SH2 domain-containing protein 3C-like isoform X5
SH2 domain-containing protein 3C-like, transcript variant X5
SH2 domain-containing protein 3C-like isoform X4
SH2 domain-containing protein 3C-like, transcript variant X7
SH2 domain-containing protein 3C-like isoform X6
formin-binding protein 1, transcript variant X2
formin-binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
formin-binding protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
formin-binding protein 1, transcript variant X4
formin-binding protein 1, transcript variant X1
formin-binding protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
formin-binding protein 1, transcript variant X9
formin-binding protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
formin-binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
formin-binding protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor 107, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein-coupled receptor 107, transcript variant X2
neuronal calcium sensor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neuronal calcium sensor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neuronal calcium sensor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal calcium sensor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
far upstream element (FUSE) binding protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
far upstream element (FUSE) binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
far upstream element (FUSE) binding protein 3, transcript variant X1
far upstream element (FUSE) binding protein 3, transcript variant X4
far upstream element-binding protein 3 isoform X2
far upstream element-binding protein 3 isoform X3
far upstream element-binding protein 3 isoform X1
far upstream element-binding protein 3 isoform X4
argininosuccinate synthase 1, transcript variant X1
argininosuccinate synthase 1, transcript variant X2
adenylate kinase isoenzyme 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
adenylate kinase isoenzyme 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenylate kinase isoenzyme 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adenylate kinase isoenzyme 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
adenylate kinase isoenzyme 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
adenylate kinase isoenzyme 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adenylate kinase isoenzyme 5-like isoform X1
adenylate kinase isoenzyme 1-like isoform X2
adenylate kinase isoenzyme 1-like isoform X4
adenylate kinase isoenzyme 1-like isoform X3
spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
26S proteasome non-ATPase regulatory subunit 5
coiled-coil domain containing 180, transcript variant X1
coiled-coil domain containing 180, transcript variant X2
coiled-coil domain-containing protein 180 isoform X1
coiled-coil domain-containing protein 180 isoform X2
ral guanine nucleotide dissociation stimulator-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like isoform X4
ral guanine nucleotide dissociation stimulator-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like isoform X3
ral guanine nucleotide dissociation stimulator-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like, transcript variant X5
ral guanine nucleotide dissociation stimulator-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ral guanine nucleotide dissociation stimulator-like isoform X1
ral guanine nucleotide dissociation stimulator-like isoform X5
ral guanine nucleotide dissociation stimulator-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
cilia and flagella associated protein 157
cilia- and flagella-associated protein 157
cerebral endothelial cell adhesion molecule, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cerebral endothelial cell adhesion molecule, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
long-chain fatty acid transport protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ubiquitin related modifier 1, transcript variant X2
ubiquitin related modifier 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
potassium sodium-activated channel subfamily T member 1b, transcript variant X1
potassium sodium-activated channel subfamily T member 1b, transcript variant X3
potassium sodium-activated channel subfamily T member 1b, transcript variant X2
potassium sodium-activated channel subfamily T member 1b, transcript variant X4
potassium channel subfamily T member 1 isoform X1
potassium channel subfamily T member 1 isoform X3
potassium channel subfamily T member 1 isoform X2
potassium channel subfamily T member 1 isoform X4
potassium sodium-activated channel subfamily T member 1b, transcript variant X5
potassium channel subfamily T member 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125465302, transcript variant X3
uncharacterized LOC125465302, transcript variant X2
uncharacterized LOC125465302, transcript variant X1
uncharacterized protein LOC125465302 isoform X3
uncharacterized protein LOC125465302 isoform X2
uncharacterized protein LOC125465302 isoform X1
calmodulin regulated spectrin-associated protein 1b, transcript variant X4
calmodulin regulated spectrin-associated protein 1b, transcript variant X3
calmodulin regulated spectrin-associated protein 1b, transcript variant X2
calmodulin regulated spectrin-associated protein 1b, transcript variant X1
calmodulin-regulated spectrin-associated protein 1-B isoform X4
calmodulin-regulated spectrin-associated protein 1-B isoform X3
calmodulin-regulated spectrin-associated protein 1-B isoform X2
calmodulin-regulated spectrin-associated protein 1-B isoform X1
ubiquitin-associated domain-containing protein 1
xenotropic and polytropic retrovirus receptor 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
nucleus accumbens-associated protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nucleus accumbens-associated protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleus accumbens-associated protein 2-like, transcript variant X6
nucleus accumbens-associated protein 2-like, transcript variant X4
nucleus accumbens-associated protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleus accumbens-associated protein 2-like, transcript variant X3
nucleus accumbens-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
quiescin Q6 sulfhydryl oxidase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
quiescin Q6 sulfhydryl oxidase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
quiescin Q6 sulfhydryl oxidase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61% coverage of the annotated genomic feature by RNAseq alignments
G protein signaling modulator 1b, transcript variant X3
G protein signaling modulator 1b, transcript variant X4
G protein signaling modulator 1b, transcript variant X5
G-protein-signaling modulator 1b isoform X3
G protein signaling modulator 1b, transcript variant X6
G-protein-signaling modulator 1b isoform X4
G protein signaling modulator 1b, transcript variant X2
G-protein-signaling modulator 1b isoform X2
G protein signaling modulator 1b, transcript variant X8
G protein signaling modulator 1b, transcript variant X1
G-protein-signaling modulator 1b isoform X1
G protein signaling modulator 1b, transcript variant X7
G-protein-signaling modulator 1b isoform X5
G protein signaling modulator 1b, transcript variant X9
G-protein-signaling modulator 1b isoform X6
uncharacterized LOC125465559, transcript variant X4
uncharacterized LOC125465559, transcript variant X3
uncharacterized LOC125465559, transcript variant X8
uncharacterized LOC125465559, transcript variant X1
G protein signaling modulator 1b, transcript variant X11
G protein signaling modulator 1b, transcript variant X10
uncharacterized LOC125465559, transcript variant X6
G-protein-signaling modulator 1b isoform X7
G protein signaling modulator 1b, transcript variant X12
uncharacterized protein LOC125465559 isoform X2
G-protein-signaling modulator 1b isoform X8
uncharacterized LOC125465559, transcript variant X7
uncharacterized LOC125465559, transcript variant X5
uncharacterized LOC125465559, transcript variant X2
uncharacterized protein LOC125465559 isoform X1
ubiquitin specific peptidase 20, transcript variant X1
ubiquitin specific peptidase 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 20 isoform X1
ubiquitin carboxyl-terminal hydrolase 20 isoform X2
chromosome 28 C9orf78 homolog, transcript variant X1
chromosome 28 C9orf78 homolog, transcript variant X2
telomere length and silencing protein 1 homolog isoform X1
telomere length and silencing protein 1 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
collagen, type XXVII, alpha 1b, transcript variant X2
collagen alpha-1(XXVII) chain B isoform X2
collagen, type XXVII, alpha 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen alpha-1(XXVII) chain B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
allograft inflammatory factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
allograft inflammatory factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
nuclear pore complex protein Nup214 isoform X1
nuclear pore complex protein Nup214 isoform X2
nuclear pore complex protein Nup214 isoform X3
uncharacterized LOC125465235, transcript variant X1
uncharacterized LOC125465235, transcript variant X2
family with sequence similarity 78 member Ab, transcript variant X1
family with sequence similarity 78 member Ab, transcript variant X2
inactive phospholipid phosphatase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inactive phospholipid phosphatase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
inactive phospholipid phosphatase 7 isoform X1
inactive phospholipid phosphatase 7 isoform X2
proline-rich coiled-coil 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proline-rich coiled-coil 2B, transcript variant X3
proline-rich coiled-coil 2B, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00153
protein-O-mannosyltransferase 1, transcript variant X1
protein-O-mannosyltransferase 1, transcript variant X3
protein-O-mannosyltransferase 1, transcript variant X5
protein-O-mannosyltransferase 1, transcript variant X2
protein O-mannosyl-transferase 1 isoform X1
protein O-mannosyl-transferase 1 isoform X2
protein-O-mannosyltransferase 1, transcript variant X4
protein O-mannosyl-transferase 1 isoform X3
proline rich transmembrane protein 1B, transcript variant X2
proline rich transmembrane protein 1B, transcript variant X3
proline rich transmembrane protein 1B, transcript variant X1
proline rich transmembrane protein 1B isoform X2
proline rich transmembrane protein 1B isoform X3
proline rich transmembrane protein 1B isoform X1
phosphatidylinositol-4-phosphate 5-kinase-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4-phosphate 5-kinase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dolichyl-phosphate mannosyltransferase subunit 2, regulatory
dolichol phosphate-mannose biosynthesis regulatory protein
protein FAM102A-like, transcript variant X2
protein FAM102A-like, transcript variant X1
solute carrier family 25 member 25b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 25 member 25b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X4
solute carrier family 25 member 25b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 25 member 25b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X2
solute carrier family 25 member 25b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 25 member 25b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X5
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cip1-interacting zinc finger protein-like
prostaglandin E synthase 2-like, transcript variant X3
prostaglandin E synthase 2-like, transcript variant X1
prostaglandin E synthase 2-like, transcript variant X2
outer dense fiber of sperm tails 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
outer dense fiber of sperm tails 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
outer dense fiber of sperm tails 2a, transcript variant X3
GLE1 RNA export mediator, transcript variant X1
GLE1 RNA export mediator, transcript variant X2
GLE1 RNA export mediator, transcript variant X3
spectrin alpha, non-erythrocytic 1, transcript variant X4
spectrin alpha, non-erythrocytic 1, transcript variant X1
spectrin alpha, non-erythrocytic 1, transcript variant X5
spectrin alpha, non-erythrocytic 1, transcript variant X7
spectrin alpha, non-erythrocytic 1, transcript variant X6
spectrin alpha, non-erythrocytic 1, transcript variant X3
spectrin alpha, non-erythrocytic 1, transcript variant X2
spectrin alpha chain, non-erythrocytic 1 isoform X6
spectrin alpha chain, non-erythrocytic 1 isoform X1
spectrin alpha chain, non-erythrocytic 1 isoform X3
spectrin alpha chain, non-erythrocytic 1 isoform X2
spectrin alpha chain, non-erythrocytic 1 isoform X5
spectrin alpha chain, non-erythrocytic 1 isoform X7
spectrin alpha chain, non-erythrocytic 1 isoform X4
dynein 2 intermediate chain 2, transcript variant X2
dynein 2 intermediate chain 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
WD repeat-containing protein 34 isoform X2
WD repeat-containing protein 34 isoform X1
uncharacterized protein LOC558400 homolog, transcript variant X1
uncharacterized protein LOC558400 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein si:ch211-51h9.7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger DHHC-type palmitoyltransferase 12a, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 12a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
palmitoyltransferase ZDHHC12-A isoform X2
palmitoyltransferase ZDHHC12-A isoform X1
zyg-11 related, cell cycle regulator, transcript variant X2
zyg-11 related, cell cycle regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SPOUT domain containing methyltransferase 1, transcript variant X1
SPOUT domain containing methyltransferase 1, transcript variant X2
putative methyltransferase C9orf114 homolog isoform X1
putative methyltransferase C9orf114 homolog isoform X2
bile salt-activated lipase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bile salt-activated lipase-like isoform X4
bile salt-activated lipase-like, transcript variant X2
bile salt-activated lipase-like, transcript variant X3
bile salt-activated lipase-like, transcript variant X1
bile salt-activated lipase-like isoform X1
bile salt-activated lipase-like isoform X2
bile salt-activated lipase-like isoform X3
general transcription factor IIIC, polypeptide 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
general transcription factor 3C polypeptide 5
TSC complex subunit 1b, transcript variant X1
TSC complex subunit 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TSC complex subunit 1b, transcript variant X3
growth factor independent 1B transcription repressor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
carnitine O-acetyltransferase a, transcript variant X4
carnitine O-acetyltransferase a, transcript variant X3
carnitine O-acetyltransferase a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
carnitine O-acetyltransferase a, transcript variant X2
carnitine O-acetyltransferase isoform X2
carnitine O-acetyltransferase isoform X1
protein phosphatase 2 phosphatase activator
serine/threonine-protein phosphatase 2A activator
ankyrin repeat and SOCS box containing 6
neurogenic locus notch homolog protein 1-like, transcript variant X1
neurogenic locus notch homolog protein 1-like, transcript variant X2
neurogenic locus notch homolog protein 1-like isoform X1
neurogenic locus notch homolog protein 1-like isoform X2
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X1
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X3
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X2
protein transport protein Sec16A isoform X1
protein transport protein Sec16A isoform X2
inositol polyphosphate-5-phosphatase E, transcript variant X3
inositol polyphosphate-5-phosphatase E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
inositol polyphosphate-5-phosphatase E, transcript variant X2
phosphatidylinositol polyphosphate 5-phosphatase type IV
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phosphatidylinositol polyphosphate 5-phosphatase type IV-like, transcript variant X1
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X1
phosphatidylinositol polyphosphate 5-phosphatase type IV-like isoform X2
peptidase, mitochondrial processing subunit alpha
mitochondrial-processing peptidase subunit alpha
endosome associated trafficking regulator 1, transcript variant X1
endosome associated trafficking regulator 1, transcript variant X2
endosome-associated-trafficking regulator 1 isoform X1
endosome-associated-trafficking regulator 1 isoform X2
small nuclear RNA activating complex, polypeptide 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nuclear RNA activating complex, polypeptide 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
snRNA-activating protein complex subunit 4 isoform X1
snRNA-activating protein complex subunit 4 isoform X2
small nuclear RNA activating complex, polypeptide 4, transcript variant X3
snRNA-activating protein complex subunit 4 isoform X3
caspase recruitment domain family, member 9
caspase recruitment domain-containing protein 9
A disintegrin and metalloproteinase with thrombospondin motifs 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
calcium channel flower domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
calcium channel flower domain containing 1, transcript variant X1
calcium channel flower domain containing 1, transcript variant X4
calcium channel flower domain containing 1, transcript variant X3
calcium channel flower homolog isoform X2
calcium channel flower homolog isoform X1
calcium channel flower homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
surfeit locus protein 1, transcript variant X2
surfeit locus protein 1, transcript variant X1
surfeit locus protein 1, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
COORDINATES: nucleotide motif:Rfam:12.0:RF00069
mediator complex subunit 22, transcript variant X2
mediator complex subunit 22, transcript variant X1
mediator complex subunit 22, transcript variant X3
mediator of RNA polymerase II transcription subunit 22 isoform X1
mediator of RNA polymerase II transcription subunit 22 isoform X2
mediator of RNA polymerase II transcription subunit 22 isoform X3
protein phosphatase 1, regulatory subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
WD repeat domain 5, transcript variant X2
WD repeat domain 5, transcript variant X1
bromodomain-containing protein 3-like, transcript variant X2
bromodomain-containing protein 3-like, transcript variant X1
bromodomain-containing protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bromodomain-containing protein 3-like isoform X1
bromodomain-containing protein 3-like isoform X2
guanine nucleotide exchange factor VAV2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
retinoic acid receptor RXR-alpha-A, transcript variant X4
retinoic acid receptor RXR-alpha-A, transcript variant X3
retinoic acid receptor RXR-alpha-A, transcript variant X5
retinoic acid receptor RXR-alpha-A, transcript variant X1
retinoic acid receptor RXR-alpha-A, transcript variant X2
retinoic acid receptor RXR-alpha-A, transcript variant X6
retinoic acid receptor RXR-alpha-A isoform X2
retinoic acid receptor RXR-alpha-A isoform X1
retinoic acid receptor RXR-alpha-A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
divergent protein kinase domain 1B, transcript variant X6
divergent protein kinase domain 1B, transcript variant X2
divergent protein kinase domain 1B, transcript variant X1
divergent protein kinase domain 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
divergent protein kinase domain 1B, transcript variant X4
divergent protein kinase domain 1B, transcript variant X5
divergent protein kinase domain 1B isoform X2
divergent protein kinase domain 1B isoform X3
divergent protein kinase domain 1B isoform X1
divergent protein kinase domain 1B isoform X4
divergent protein kinase domain 1B isoform X5
divergent protein kinase domain 1B isoform X6
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)
1-acyl-sn-glycerol-3-phosphate acyltransferase beta
uncharacterized LOC125465294, transcript variant X3
uncharacterized LOC125465294, transcript variant X1
uncharacterized LOC125465294, transcript variant X2
myomaker, myoblast fusion factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myomaker, myoblast fusion factor, transcript variant X1
family with sequence similarity 163 member B, genome duplicate a